These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38466631)

  • 1. Telomeres in glioma: Maintenance mechanisms to therapeutic potential.
    Stevers NO; Costello JF
    Neuro Oncol; 2024 Jun; 26(6):1025-1026. PubMed ID: 38466631
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of telomere maintenance and associated therapeutic vulnerabilities in malignant gliomas.
    Waitkus MS; Erman EN; Reitman ZJ; Ashley DM
    Neuro Oncol; 2024 Jun; 26(6):1012-1024. PubMed ID: 38285162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induced Telomere Damage to Treat Telomerase Expressing Therapy-Resistant Pediatric Brain Tumors.
    Sengupta S; Sobo M; Lee K; Senthil Kumar S; White AR; Mender I; Fuller C; Chow LML; Fouladi M; Shay JW; Drissi R
    Mol Cancer Ther; 2018 Jul; 17(7):1504-1514. PubMed ID: 29654065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lentiviral vector mediated siRNA knock-down of hTERT results in diminished capacity in invasiveness and in vivo growth of human glioma cells in a telomere length-independent manner.
    Zhao P; Wang C; Fu Z; You Y; Cheng Y; Lu X; Lu A; Liu N; Pu P; Kang C; Salford LG; Fan X
    Int J Oncol; 2007 Aug; 31(2):361-8. PubMed ID: 17611693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive assessment of telomere maintenance mechanisms in brain tumors.
    Viswanath P; Batsios G; Mukherjee J; Gillespie AM; Larson PEZ; Luchman HA; Phillips JJ; Costello JF; Pieper RO; Ronen SM
    Nat Commun; 2021 Jan; 12(1):92. PubMed ID: 33397920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When the Ends Are Really the Beginnings: Targeting Telomerase for Treatment of GBM.
    Bollam SR; Berens ME; Dhruv HD
    Curr Neurol Neurosci Rep; 2018 Mar; 18(4):15. PubMed ID: 29525892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomere 3' overhang-specific DNA oligonucleotides induce autophagy in malignant glioma cells.
    Aoki H; Iwado E; Eller MS; Kondo Y; Fujiwara K; Li GZ; Hess KR; Siwak DR; Sawaya R; Mills GB; Gilchrest BA; Kondo S
    FASEB J; 2007 Sep; 21(11):2918-30. PubMed ID: 17449721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variants in telomerase-related genes are associated with an older age at diagnosis in glioma patients: evidence for distinct pathways of gliomagenesis.
    Walsh KM; Rice T; Decker PA; Kosel ML; Kollmeyer T; Hansen HM; Zheng S; McCoy LS; Bracci PM; Anderson E; Hsuang G; Wiemels JL; Pico AR; Smirnov I; Molinaro AM; Tihan T; Berger MS; Chang SM; Prados MD; Lachance DH; Sicotte H; Eckel-Passow JE; Wiencke JK; Jenkins RB; Wrensch MR
    Neuro Oncol; 2013 Aug; 15(8):1041-7. PubMed ID: 23733245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomas.
    Dorris K; Sobo M; Onar-Thomas A; Panditharatna E; Stevenson CB; Gardner SL; Dewire MD; Pierson CR; Olshefski R; Rempel SA; Goldman S; Miles L; Fouladi M; Drissi R
    J Neurooncol; 2014 Mar; 117(1):67-76. PubMed ID: 24477622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A preclinical mouse model of glioma with an alternative mechanism of telomere maintenance (ALT).
    Jeitany M; Pineda JR; Liu Q; Porreca RM; Hoffschir F; Desmaze C; Silvestre DC; Mailliet P; Junier MP; Londoño-Vallejo A; Ségal-Bendirdjian E; Chneiweiss H; Boussin FD
    Int J Cancer; 2015 Apr; 136(7):1546-58. PubMed ID: 25175359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mTOR: a new therapeutic target for pediatric low-grade glioma?
    Rodriguez FJ; Raabe EH
    CNS Oncol; 2014 Mar; 3(2):89-91. PubMed ID: 25055011
    [No Abstract]   [Full Text] [Related]  

  • 12. Alternative lengthening of telomeres in human glioma stem cells.
    Silvestre DC; Pineda JR; Hoffschir F; Studler JM; Mouthon MA; Pflumio F; Junier MP; Chneiweiss H; Boussin FD
    Stem Cells; 2011 Mar; 29(3):440-51. PubMed ID: 21425407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meningiomas, dicentric chromosomes, gliomas, and telomerase activity.
    Carroll T; Maltby E; Brock I; Royds J; Timperley W; Jellinek D
    J Pathol; 1999 Aug; 188(4):395-9. PubMed ID: 10440750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of telomere maintenance in the spontaneous growth arrest of pediatric low-grade gliomas.
    Tabori U; Vukovic B; Zielenska M; Hawkins C; Braude I; Rutka J; Bouffet E; Squire J; Malkin D
    Neoplasia; 2006 Feb; 8(2):136-42. PubMed ID: 16611406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective antitumor immunity against murine gliomas using dendritic cells transduced with hTERTC27 recombinant adenovirus.
    Gong HX; He L; Li XP; Wang YD; Li Y; Huang JJ; Wang Z; Xie D; Kung HF; Peng Y
    Oncol Rep; 2012 Apr; 27(4):1163-9. PubMed ID: 22210010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal.
    Killela PJ; Reitman ZJ; Jiao Y; Bettegowda C; Agrawal N; Diaz LA; Friedman AH; Friedman H; Gallia GL; Giovanella BC; Grollman AP; He TC; He Y; Hruban RH; Jallo GI; Mandahl N; Meeker AK; Mertens F; Netto GJ; Rasheed BA; Riggins GJ; Rosenquist TA; Schiffman M; Shih IeM; Theodorescu D; Torbenson MS; Velculescu VE; Wang TL; Wentzensen N; Wood LD; Zhang M; McLendon RE; Bigner DD; Kinzler KW; Vogelstein B; Papadopoulos N; Yan H
    Proc Natl Acad Sci U S A; 2013 Apr; 110(15):6021-6. PubMed ID: 23530248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adult diffuse glioma: genetic heterogeneity and therapeutic implications].
    Verreault M; Delattre JY; Idbaih A
    Med Sci (Paris); 2012 Oct; 28(10):813-6. PubMed ID: 23067408
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of the alternative lengthening of telomeres pathway in malignant gliomas for improved molecular diagnosis.
    Fogli A; Demattei MV; Corset L; Vaurs-Barrière C; Chautard E; Biau J; Kémény JL; Godfraind C; Pereira B; Khalil T; Grandin N; Arnaud P; Charbonneau M; Verrelle P
    J Neurooncol; 2017 Nov; 135(2):381-390. PubMed ID: 28755323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between IDH, ATRX, and TERT promoter mutations in glioma.
    Ohba S; Kuwahara K; Yamada S; Abe M; Hirose Y
    Brain Tumor Pathol; 2020 Apr; 37(2):33-40. PubMed ID: 32227259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human TERT promoter mutations as a prognostic biomarker in glioma.
    Powter B; Jeffreys SA; Sareen H; Cooper A; Brungs D; Po J; Roberts T; Koh ES; Scott KF; Sajinovic M; Vessey JY; de Souza P; Becker TM
    J Cancer Res Clin Oncol; 2021 Apr; 147(4):1007-1017. PubMed ID: 33547950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.